A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell engager." This type of immunotherapy ignites our own ...

An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...

Vir has a promising pipeline, and expects to report data this year on several phase 2 clinical trials. Vir's revenue rose by 133.4% last year. The Food and Drug Administration recently made a decision ...

Vir Das will perform at London’s Royal Albert Hall for the first time with his Hey Stranger tour, marking a historic moment for Indian stand-up comedy on the global stage.

GSK is walking away from a core piece of its $345 million bet on Vir Biotechnology. The partners have ended their collaboration on anti-influenza antibodies, freeing Vir to “actively” pitch the ...

In a thought-provoking post-Oscars discussion, Vir Das raised eyebrows about India's absence of a 'Conan-style' approach to ...

Vir Das has shared that award shows in India cannot include hosts like Conan O'Brien or Ricky Gervais because stars cannot handle jokes here.

HALIFAX COUNTY, Va. (WDBJ) - A core piece of history is growing at the Virginia International Raceway. Many people don’t tend to think about trees when they’re at a racetrack, but for VIR fans, that’s ...

On Wednesday, Vir Biotechnology, Inc. (NASDAQ:VIR) stock traded higher after the company presented initial Phase 1 data from two of its dual-masked T-cell engagers (TCEs): VIR-5818, which targets a ...

UKRAINE - 2022/01/23: In this photo illustration, a Vir Biotechnology logo is seen on a smartphone and a computer screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images) ...